drugset / Trial / NCT01614366
DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension
Non-randomizedFactorialSingle-blindTreatment
Summary
The purpose of this study is to compare the different dose of DMTA07 (DM) combine with amlodipine in the treatment of mild to moderate essential hypertension, and to define the optimized dose of DM in the combination therapy.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DMTA07 | Unknown | 0 mg | — |
| Subject | DMTA07 | Unknown | 2.5 mg | — |
| Subject | DMTA07 | Unknown | 7.5 mg | — |
| Subject | DMTA07 | Unknown | 30 mg | — |
| Background | Amlodipine | Other / unclassified | 5 mg | — |